Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 244

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

The significance of intertumor and intratumor heterogeneity in liver cancer

Open access
Liu, Jinping, Dang, Hien, Wang, Xin Wei · 2018 · Experimental & Molecular Medicine

Abstract

Genomic analyses of primary liver cancer samples reveal a complex mutational landscape with vast intertumor and intratumor heterogeneity. Different primary liver tumors and subclones within each tumor display striking molecular and biological variations. Consequently, tumor molecular heterogeneity contributes to drug resistance and tumor relapse following therapy, which poses a substantial obstruction to improving outcomes of patients with liver cancer. There is an urgent need to the compositional and functional understanding of tumor heterogeneity. In this review, we summarize genomic and non-genomic diversities, which include stemness and microenvironmental causes of the functional heterogeneity of the primary liver cancer ecosystem. We discuss the importance and intricacy of intratumor heterogeneity in the context of cancer cell evolution. We also discuss methodologies applicable to determine intratumor heterogeneity and highlight the best-fit patient-derived in vivo and in vitro models to recapture the functional heterogeneity of primary liver cancer with the aim to improve future therapeutic strategies. Differences in liver cancer cells within individual tumors and between different tumors obstruct treatment and justify intensive research. Primary liver cancer is the second most lethal cancer worldwide and its incidence is increasing. Xin Wei Wang and colleagues at the National Cancer Institute in Bethesda, Maryland, USA, reviewed research on the genetic and non-genetic diversity of liver cancer cells. Extensive intra-tumor and inter-tumor heterogeneity contributes significantly to drug resistance and tumor relapse following therapy. The heterogeneity includes variations in stem cell character and other factors which can lead to different pathways of cancer progression. The authors discuss the methods available to analyze liver tumor heterogeneity and to use the results to devise optimum therapy strategies for individual patients. They conclude there is an urgent need to learn more about tumor cell heterogeneity in liver cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/emm.2017.165

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 17 references

Cited by

See all 244

Metadata

Authors
Liu, J., Dang, H., & Wang, X. W.
Venue
Experimental & Molecular Medicine
Published
2018-01
Volume
50
Issue
1
Pages
e416-e416
ISSN
  • 1226-3613 (ISSN-L)
  • 2092-6413
OpenAlex
W2782063681
Cited by
244
References
17
FWCI
5.96
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The significance of intertumor and intratumor heterogeneity in liver cancer. https://app.cochat.ai/papers/10.1038/emm.2017.165
The paper
Liu, J., Dang, H., & Wang, X. W. (2018). The significance of intertumor and intratumor heterogeneity in liver cancer. Experimental & Molecular Medicine. https://doi.org/10.1038/emm.2017.165

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.